Form 424B3 - Prospectus [Rule 424(b)(3)]:
SEC Accession No. 0000950170-22-016906
Filing Date
2022-08-11
Accepted
2022-08-11 16:25:35
Documents
6

Document Format Files

Seq Description Document Type Size
1 424B3 424b3_-_btxq2-2022.htm 424B3 1748028
2 EX-31.1 bttx-ex31_1.htm EX-31.1 20685
3 EX-31.2 bttx-ex31_2.htm EX-31.2 20712
4 EX-32.1 bttx-ex32_1.htm EX-32.1 12160
5 EX-32.2 bttx-ex32_2.htm EX-32.2 11655
6 GRAPHIC img159823054_0.jpg GRAPHIC 5458
  Complete submission text file 0000950170-22-016906.txt   1821971
Mailing Address 548 MARKET ST. #49404 SAN FRANCISCO CA 94101
Business Address 548 MARKET ST. #49404 SAN FRANCISCO CA 94101 415-887-2311
Better Therapeutics, Inc. (Filer) CIK: 0001832415 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B3 | Act: 33 | File No.: 333-261383 | Film No.: 221156258
SIC: 8000 Services-Health Services